CDX2 and acute myeloid leukemia: The researchers also demonstrated decreased CDX2 mRNA expression levels that were positively correlated with miR-125b levels after ATRA treatment, suggesting a potential function of CDX2 and miR-125b in inhibiting cell differentiation in AML cells and promoting leukemogenesis.